Oncology Medical Billing Services

Why Oncology Practices Choose Atlas Billers

Oncology billing is among the most complex in all of medicine. Between chemotherapy drug administration codes (96401–96549), radiation treatment delivery (77401–77423), and the constantly shifting landscape of HCPCS J-codes for injectable drugs, a single coding error can cost your practice thousands of dollars per patient encounter. Many general billing companies lack the specialized knowledge to correctly sequence multi-modality treatment plans.

Atlas Billers assigns certified oncology coding specialists who understand drug waste billing, treatment planning hierarchies, and the nuances of bundling rules specific to medical and radiation oncology. We track NDC-to-J-code crosswalks in real time and ensure your practice captures every billable unit of chemotherapy administration, hydration, and supportive infusion therapy.

Common Oncology Billing Challenges

Complex Chemotherapy Drug Billing and J-Code Management

HCPCS J-codes change frequently, and incorrect unit calculations on high-cost drugs like pembrolizumab or bevacizumab can result in underpayments of hundreds or thousands of dollars per infusion session. Accurate drug waste reporting under JW modifiers is equally critical.

Radiation Therapy Planning and Delivery Code Sequencing

Radiation oncology requires precise sequencing of treatment planning (77261–77263), dosimetry (77300), simulation (77280–77290), and delivery codes. Errors in technical vs. professional component billing lead to systematic revenue loss.

Prior Authorization Delays for High-Cost Infusion Therapies

Many payers require step therapy documentation or genetic testing results before approving targeted therapies and immunotherapies. Delays in obtaining authorizations can stall treatment and create cash flow gaps.

Bundling Errors on Multi-Modality Treatment Plans

When patients receive concurrent chemotherapy and radiation, or when multiple infusion drugs are administered in a single session, improper bundling and sequencing of add-on codes is a leading cause of denials.

How Atlas Billers Maximizes Your Oncology Revenue

Our oncology billing team monitors drug pricing updates, payer-specific coverage policies, and NCCN guideline changes that directly impact reimbursement. We perform pre-submission audits on every high-dollar claim to ensure correct J-code assignment, unit calculations, and modifier usage before the claim ever leaves your practice.

• Specialty-Trained Coders: Certified coders with oncology-specific experience in medical oncology, radiation oncology, and hematology billing
• Proactive Denial Management: We prevent denials before they happen through real-time eligibility checks and prior authorization tracking for all infusion therapies
• Weekly Transparency Reports: Every Monday, see exactly where your revenue stands — including drug reimbursement vs. acquisition cost analysis
• Staff Training: We train your infusion nurses and front desk staff on documentation requirements that directly impact chemotherapy billing accuracy

Frequently Asked Questions

How does Atlas handle chemotherapy drug waste billing?

We track every vial used during infusion sessions and ensure proper JW modifier reporting for discarded drug. Our team reconciles drug purchase records against billed units to capture all legitimate waste revenue, which can represent tens of thousands of dollars annually for busy oncology practices.

What is your first-pass claim acceptance rate for oncology?

Our oncology practices consistently achieve first-pass rates above 96%, compared to the industry average of 80-85%.

How long does it take to transition from our current biller?

Our parallel transition takes approximately 30 days with zero disruption to your cash flow.

Do you provide a dedicated billing manager?

Yes. Every Atlas client gets a dedicated billing manager with a direct phone number you can call or text anytime.